A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance. Issue 8 (18th August 2016)
- Record Type:
- Journal Article
- Title:
- A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance. Issue 8 (18th August 2016)
- Main Title:
- A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
- Authors:
- Vincent, Benjamin M.
Langlois, Jean-Baptiste
Srinivas, Raja
Lancaster, Alex K.
Scherz-Shouval, Ruth
Whitesell, Luke
Tidor, Bruce
Buchwald, Stephen L.
Lindquist, Susan - Abstract:
- Summary: To cause disease, a microbial pathogen must adapt to the challenges of its host environment. The leading fungal pathogen Candida albicans colonizes nutrient-poor bodily niches, withstands attack from the immune system, and tolerates treatment with azole antifungals, often evolving resistance. To discover agents that block these adaptive strategies, we screened 300, 000 compounds for inhibition of azole tolerance in a drug-resistant Candida isolate. We identified a novel indazole derivative that converts azoles from fungistatic to fungicidal drugs by selective inhibition of mitochondrial cytochrome bc 1 . We synthesized 103 analogs to optimize potency (half maximal inhibitory concentration 0.4 μM) and fungal selectivity (28-fold over human). In addition to reducing azole resistance, targeting cytochrome bc 1 prevents C. albicans from adapting to the nutrient-deprived macrophage phagosome and greatly curtails its virulence in mice. Inhibiting mitochondrial respiration and restricting metabolic flexibility with this synthetically tractable chemotype provides an attractive therapeutic strategy to limit both fungal virulence and drug resistance. Graphical Abstract: Highlights: 300, 000 compound screen identifies indazole that reverses fluconazole resistance Target identified as mitochondrial cytochrome bc 1 Optimized potency and fungal selectivity through chemical synthesis Impairing cytochrome bc 1 restricts carbon source utilization and virulence Abstract : VincentSummary: To cause disease, a microbial pathogen must adapt to the challenges of its host environment. The leading fungal pathogen Candida albicans colonizes nutrient-poor bodily niches, withstands attack from the immune system, and tolerates treatment with azole antifungals, often evolving resistance. To discover agents that block these adaptive strategies, we screened 300, 000 compounds for inhibition of azole tolerance in a drug-resistant Candida isolate. We identified a novel indazole derivative that converts azoles from fungistatic to fungicidal drugs by selective inhibition of mitochondrial cytochrome bc 1 . We synthesized 103 analogs to optimize potency (half maximal inhibitory concentration 0.4 μM) and fungal selectivity (28-fold over human). In addition to reducing azole resistance, targeting cytochrome bc 1 prevents C. albicans from adapting to the nutrient-deprived macrophage phagosome and greatly curtails its virulence in mice. Inhibiting mitochondrial respiration and restricting metabolic flexibility with this synthetically tractable chemotype provides an attractive therapeutic strategy to limit both fungal virulence and drug resistance. Graphical Abstract: Highlights: 300, 000 compound screen identifies indazole that reverses fluconazole resistance Target identified as mitochondrial cytochrome bc 1 Optimized potency and fungal selectivity through chemical synthesis Impairing cytochrome bc 1 restricts carbon source utilization and virulence Abstract : Vincent et al. use a phenotypic screen to discover and optimize a series of indazoles that reverse resistance to triazole antifungals in the pathogenic fungus C. albicans . The indazoles target cytochrome bc 1, restricting carbon source utilization, macrophage escape, and virulence. … (more)
- Is Part Of:
- Cell chemical biology. Volume 23:Issue 8(2016)
- Journal:
- Cell chemical biology
- Issue:
- Volume 23:Issue 8(2016)
- Issue Display:
- Volume 23, Issue 8 (2016)
- Year:
- 2016
- Volume:
- 23
- Issue:
- 8
- Issue Sort Value:
- 2016-0023-0008-0000
- Page Start:
- 978
- Page End:
- 991
- Publication Date:
- 2016-08-18
- Subjects:
- Biochemistry -- Periodicals
572.05 - Journal URLs:
- http://www.cell.com/cell-chemical-biology/home ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.chembiol.2016.06.016 ↗
- Languages:
- English
- ISSNs:
- 2451-9456
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3097.733000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 248.xml